Items tagged with Drug-resistant TB
Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments (post with simple image)
Médecins Sans Frontières released the 4th edition of its report DR-TB Drugs Under the Microscope. The report analyzes the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis.
Advocates call for WHO to update Delamanid Guidance to include children (post with simple image)
On World TB Day, and in light of new evidence of safety in children, advocates called on the World Health Organization to update its 2014 guidance on delamanid to include children.
Advocates, alarmed by appalling global response to MDR-TB outbreak in Papua New Guinea, call on international agencies to take action (post with simple image)
Advocates denounced the global response to an MDR-TB outbreak in Papua New Guinea and urged international agencies to immediately intervene.
STREAM Stage 2 Trial begins (post with simple image)
Stage 2 of trial aims to reduce MDR-TB treatment from 24 months to 6 or 9 months.
New Indian guidelines on the use of bedaquiline (post with simple image)
The Indian Ministry of Health and Family Welfare released Guidelines for use of Bedaquiline in RNTCP through conditional access under Programmatic Management of Drug Resistant Tuberculosis in India.
World Health Organization recommends shorter treatment for multidrug-resistant TB (post with simple image)
New World Health Organization recommendations aim to speed up detection and improve treatment outcomes for multidrug-resistant TB through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.
Rapid Clinical Advice on new TB drugs in children (post with simple image)
The Sentinel Project’s Advocacy Task Force has developed Rapid Clinical Advice on the use of new TB drugs bedaquiline and delamanid in children.
Tackling drug-resistant infections globally: final report and recommendations (post with simple image)
The Review on Antimicrobial Resistance released its final report and recommendations warning that antimicrobial-resistant infections such as drug-resistant tuberculosis could kill 10 million people a year by 2050 without an urgent expansion of resources and funds.
Call to Action to accelerate access to DR-TB drugs: 2016 update (post with simple image)
The update informs about the general progress in the introduction of bedaquiline and delamanid in TB programs worldwide and reports on the requests made in the Call to Action issued in March 2015.
Advocates call on pharma companies to improve access to MDR-TB drugs (post with simple image)
TB advocates urge Janssen and Otsuka to improve the affordability and availability of bedaquiline and delamanid.
Page 71 of 76 · Total posts: 0←First 70 71 72 Last→